HEADER HYDROLASE/HYDROLASE INHIBITOR 08-DEC-14 4X6P TITLE FACTOR XIA (PICHIA PASTORIS; C500S [C122S]) IN COMPLEX WITH THE TITLE 2 INHIBITOR (2E)-N-{(1S)-1-[4-(3-AMINO-1H-INDAZOL-6-YL)-1H-IMIDAZOL-2- TITLE 3 YL]-2-PHENYLETHYL}-3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2- TITLE 4 ENAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XI, LIGHT CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FXI,PLASMA THROMBOPLASTIN ANTECEDENT,PTA; COMPND 5 EC: 3.4.21.27; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F11; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: PICHIA PASTORIS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SMD1168H; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PPICZALPHAA KEYWDS SERINE PROTEASE, BLOOD COAGULATION FACTOR, PROTEIN INHIBITOR COMPLEX, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 5 27-SEP-23 4X6P 1 HETSYN REVDAT 4 29-JUL-20 4X6P 1 COMPND SOURCE JRNL REMARK REVDAT 4 2 1 HETNAM LINK SITE REVDAT 3 01-APR-15 4X6P 1 JRNL REVDAT 2 18-MAR-15 4X6P 1 JRNL REVDAT 1 18-FEB-15 4X6P 0 JRNL AUTH D.J.PINTO,J.M.SMALLHEER,J.R.CORTE,E.J.AUSTIN,C.WANG,T.FANG, JRNL AUTH 2 L.M.SMITH,K.A.ROSSI,A.R.RENDINA,J.M.BOZARTH,G.ZHANG,A.WEI, JRNL AUTH 3 V.RAMAMURTHY,S.SHERIFF,J.E.MYERS,P.E.MORIN,J.M.LUETTGEN, JRNL AUTH 4 D.A.SEIFFERT,M.L.QUAN,R.R.WEXLER JRNL TITL STRUCTURE-BASED DESIGN OF INHIBITORS OF COAGULATION FACTOR JRNL TITL 2 XIA WITH NOVEL P1 MOIETIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 1635 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 25728130 JRNL DOI 10.1016/J.BMCL.2015.01.028 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.L.QUAN,P.C.WONG,C.WANG,F.WOERNER,J.M.SMALLHEER, REMARK 1 AUTH 2 F.A.BARBERA,J.M.BOZARTH,R.L.BROWN,M.R.HARPEL,J.M.LUETTGEN, REMARK 1 AUTH 3 P.E.MORIN,T.PETERSON,V.RAMAMURTHY,A.R.RENDINA,K.A.ROSSI, REMARK 1 AUTH 4 C.A.WATSON,A.WEI,G.ZHANG,D.SEIFFERT,R.R.WEXLER REMARK 1 TITL TETRAHYDROQUINOLINE DERIVATIVES AS POTENT AND SELECTIVE REMARK 1 TITL 2 FACTOR XIA INHIBITORS. REMARK 1 REF J.MED.CHEM. V. 57 955 2014 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 24405333 REMARK 1 DOI 10.1021/JM401670X REMARK 1 REFERENCE 2 REMARK 1 AUTH J.J.HANGELAND,T.J.FRIENDS,K.A.ROSSI,J.M.SMALLHEER,C.WANG, REMARK 1 AUTH 2 Z.SUN,J.R.CORTE,T.FANG,P.C.WONG,A.R.RENDINA,F.A.BARBERA, REMARK 1 AUTH 3 J.M.BOZARTH,J.M.LUETTGEN,C.A.WATSON,G.ZHANG,A.WEI, REMARK 1 AUTH 4 V.RAMAMURTHY,P.E.MORIN,G.S.BISACCHI,S.SUBRAMANIAM, REMARK 1 AUTH 5 P.ARUNACHALAM,A.MATHUR,D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN REMARK 1 TITL PHENYLIMIDAZOLES AS POTENT AND SELECTIVE INHIBITORS OF REMARK 1 TITL 2 COAGULATION FACTOR XIA WITH IN VIVO ANTITHROMBOTIC ACTIVITY. REMARK 1 REF J.MED.CHEM. V. 57 9915 2014 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 25405503 REMARK 1 DOI 10.1021/JM5010607 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.R.CORTE,T.FANG,J.J.HANGELAND,T.J.FRIENDS,A.R.RENDINA, REMARK 1 AUTH 2 J.M.LUETTGEN,J.M.BOZARTH,F.A.BARBERA,K.A.ROSSI,A.WEI, REMARK 1 AUTH 3 V.RAMAMURTHY,P.E.MORIN,D.A.SEIFFERT,R.R.WEXLER,M.L.QUAN REMARK 1 TITL PYRIDINE AND PYRIDINONE-BASED FACTOR XIA INHIBITORS. REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 25 925 2015 REMARK 1 REFN ESSN 1464-3405 REMARK 1 PMID 25592713 REMARK 1 DOI 10.1016/J.BMCL.2014.12.050 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 37771 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1893 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2917 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1887 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2773 REMARK 3 BIN R VALUE (WORKING SET) : 0.1865 REMARK 3 BIN FREE R VALUE : 0.2324 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 144 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3684 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 157 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.68310 REMARK 3 B22 (A**2) : -1.64490 REMARK 3 B33 (A**2) : -0.03820 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.171 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.147 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.128 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.142 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.126 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4049 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5550 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1378 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 719 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4049 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 523 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : 4 ; 1.000 ; HARMONIC REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4712 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.95 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.34 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4X6P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000205180. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAR-14 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38006 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 41.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.51700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3SOR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE, PH 5.0, REMARK 280 36%(W/V) PEG4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.36950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.36950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.88700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.27450 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.88700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.27450 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 77.36950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.88700 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 41.27450 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 77.36950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.88700 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 41.27450 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAIN A REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 244 REMARK 465 VAL A 245 REMARK 465 ALA B 244 REMARK 465 VAL B 245 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 61 CG CD OE1 OE2 REMARK 470 LYS A 64 CD CE NZ REMARK 470 LYS A 95 CD CE NZ REMARK 470 ARG A 119 CZ NH1 NH2 REMARK 470 ARG A 129 NE CZ NH1 NH2 REMARK 470 ARG A 148 CD NE CZ NH1 NH2 REMARK 470 ARG A 172 CD NE CZ NH1 NH2 REMARK 470 GLN A 243 CD OE1 NE2 REMARK 470 GLU B 61 CG CD OE1 OE2 REMARK 470 LYS B 64 CD CE NZ REMARK 470 LYS B 126 CD CE NZ REMARK 470 ARG B 129 CG CD NE CZ NH1 NH2 REMARK 470 ASN B 130 CG OD1 ND2 REMARK 470 ILE B 132 CG1 CG2 CD1 REMARK 470 ARG B 148 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 172 CD NE CZ NH1 NH2 REMARK 470 GLN B 243 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE B 132 C - N - CA ANGL. DEV. = 16.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 95 -50.89 -127.28 REMARK 500 ASP A 149 -152.98 -151.58 REMARK 500 TYR A 171 56.16 -116.41 REMARK 500 SER A 214 -65.81 -122.72 REMARK 500 LYS B 95 -51.94 -128.45 REMARK 500 ILE B 132 26.77 93.44 REMARK 500 ASP B 149 -151.79 -152.69 REMARK 500 TYR B 171 63.42 -116.80 REMARK 500 SER B 214 -65.35 -122.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4X6M RELATED DB: PDB REMARK 900 RELATED ID: 4X6N RELATED DB: PDB REMARK 900 RELATED ID: 4X6O RELATED DB: PDB DBREF 4X6P A 16 245 UNP P03951 FA11_HUMAN 388 625 DBREF 4X6P B 16 245 UNP P03951 FA11_HUMAN 388 625 SEQADV 4X6P SER A 122 UNP P03951 CYS 500 ENGINEERED MUTATION SEQADV 4X6P SER B 122 UNP P03951 CYS 500 ENGINEERED MUTATION SEQRES 1 A 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 A 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 A 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 A 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 A 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER SEQRES 6 A 238 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 A 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 A 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN SEQRES 9 A 238 TYR THR ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS SEQRES 10 A 238 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 A 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 A 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 A 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 A 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 A 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 A 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 A 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 A 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 A 238 THR GLN ALA VAL SEQRES 1 B 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 B 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 B 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 B 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 B 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER SEQRES 6 B 238 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 B 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 B 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN SEQRES 9 B 238 TYR THR ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS SEQRES 10 B 238 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 B 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 B 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 B 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 B 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 B 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 B 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 B 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 B 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 B 238 THR GLN ALA VAL HET NAG A 301 14 HET 3YU A 302 63 HET CIT A 303 13 HET GOL A 304 6 HET NAG B 301 14 HET 3YU B 302 63 HET GOL B 303 6 HET GOL B 304 6 HET GOL B 305 6 HET GOL B 306 6 HET GOL B 307 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 3YU (2E)-N-{(1S)-1-[4-(3-AMINO-1H-INDAZOL-6-YL)-1H- HETNAM 2 3YU IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[5-CHLORO-2-(1H- HETNAM 3 3YU TETRAZOL-1-YL)PHENYL]PROP-2-ENAMIDE HETNAM CIT CITRIC ACID HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 3YU 2(C28 H23 CL N10 O) FORMUL 5 CIT C6 H8 O7 FORMUL 6 GOL 6(C3 H8 O3) FORMUL 14 HOH *306(H2 O) HELIX 1 AA1 ALA A 55 TYR A 58B 5 6 HELIX 2 AA2 SER A 62 LYS A 64 5 3 HELIX 3 AA3 ASN A 72 ILE A 76 5 5 HELIX 4 AA4 MET A 96 GLY A 100 5 5 HELIX 5 AA5 SER A 125 ARG A 129 5 5 HELIX 6 AA6 THR A 164 TYR A 171 1 9 HELIX 7 AA7 TYR A 234 GLN A 243 1 10 HELIX 8 AA8 ALA B 55 TYR B 58B 5 6 HELIX 9 AA9 SER B 62 LYS B 64 5 3 HELIX 10 AB1 ASN B 72 ILE B 76 5 5 HELIX 11 AB2 MET B 96 GLY B 100 5 5 HELIX 12 AB3 SER B 125 ARG B 129 5 5 HELIX 13 AB4 THR B 164 TYR B 171 1 9 HELIX 14 AB5 TYR B 234 THR B 242 1 9 SHEET 1 AA1 8 THR A 20 ALA A 21 0 SHEET 2 AA1 8 GLN A 156 LYS A 159 -1 O LYS A 157 N THR A 20 SHEET 3 AA1 8 CYS A 136 GLY A 140 -1 N GLY A 140 O GLN A 156 SHEET 4 AA1 8 PRO A 198 HIS A 203 -1 O SER A 200 N TRP A 137 SHEET 5 AA1 8 VAL A 206 TRP A 215 -1 O VAL A 206 N HIS A 203 SHEET 6 AA1 8 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 AA1 8 MET A 180 ALA A 183 -1 N ILE A 181 O TYR A 228 SHEET 8 AA1 8 LEU A 162 VAL A 163 -1 N VAL A 163 O CYS A 182 SHEET 1 AA2 6 LEU A 65A TYR A 67 0 SHEET 2 AA2 6 GLN A 30 THR A 35 -1 N HIS A 34 O ARG A 65B SHEET 3 AA2 6 ARG A 39 GLY A 48 -1 O CYS A 42 N LEU A 33 SHEET 4 AA2 6 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 5 AA2 6 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 6 AA2 6 VAL A 85 ILE A 90 -1 N ILE A 89 O LEU A 105 SHEET 1 AA3 8 THR B 20 ALA B 21 0 SHEET 2 AA3 8 GLN B 156 LYS B 159 -1 O LYS B 157 N THR B 20 SHEET 3 AA3 8 CYS B 136 GLY B 140 -1 N GLY B 140 O GLN B 156 SHEET 4 AA3 8 PRO B 198 HIS B 203 -1 O SER B 200 N TRP B 137 SHEET 5 AA3 8 VAL B 206 TRP B 215 -1 O VAL B 206 N HIS B 203 SHEET 6 AA3 8 GLY B 226 ASN B 230 -1 O VAL B 227 N TRP B 215 SHEET 7 AA3 8 MET B 180 ALA B 183 -1 N ILE B 181 O TYR B 228 SHEET 8 AA3 8 LEU B 162 VAL B 163 -1 N VAL B 163 O CYS B 182 SHEET 1 AA4 6 LEU B 65A TYR B 67 0 SHEET 2 AA4 6 GLN B 30 THR B 35 -1 N HIS B 34 O ARG B 65B SHEET 3 AA4 6 ARG B 39 GLY B 48 -1 O LEU B 41 N LEU B 33 SHEET 4 AA4 6 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 5 AA4 6 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54 SHEET 6 AA4 6 VAL B 85 ILE B 90 -1 N ILE B 89 O LEU B 105 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.05 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.03 SSBOND 5 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 6 CYS B 136 CYS B 201 1555 1555 2.07 SSBOND 7 CYS B 168 CYS B 182 1555 1555 2.04 SSBOND 8 CYS B 191 CYS B 219 1555 1555 2.03 LINK ND2 ASN A 72 C1 NAG A 301 1555 1555 1.44 LINK ND2 ASN B 72 C1 NAG B 301 1555 1555 1.43 CISPEP 1 SER A 36A PRO A 36B 0 -5.70 CISPEP 2 SER B 36A PRO B 36B 0 -4.92 CISPEP 3 VAL B 131 ILE B 132 0 21.95 CRYST1 77.774 82.549 154.739 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012858 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012114 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006462 0.00000